Events
A multi-professional platform for oncology education and exchange, and for immense international visibility for scientific research, this year the Congress featured a...
Oxford Global’s R&D US Series features 3 outstanding programmes: our long-running 5th Annual Drug Discovery and Chemistry USA Congress, the 3rd Annual Biomarkers...
The future of immuno-oncology drug development is positioned in combination therapies, where immunotherapy modalities are tested in rational combinations with other...
The Immuno-Oncology Biomarkers Workshop will identify the next steps for action in immunotherapy biomarker development. It will provide a forum for energetic discussion...
